vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
36.52
+1.11 (3.13%)
At close: Mar 9, 2026, 4:00 PM EDT
35.79
-0.73 (-2.00%)
After-hours: Mar 9, 2026, 5:54 PM EDT
vTv Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 453 | 91 | 23 | 54 | 67 | 98 | |
| Market Cap Growth | 310.75% | 288.02% | -56.62% | -18.92% | -32.00% | 40.81% | |
| Enterprise Value | 355 | 52 | 27 | 64 | 93 | 144 | |
| Last Close Price | 36.52 | 13.81 | 11.50 | 26.51 | 39.80 | 74.40 | |
| PS Ratio | 26657.20 | 89.38 | - | 26.76 | 16.63 | 15.27 | |
| PB Ratio | 6.42 | 6.36 | -1.26 | 9.25 | 4.38 | 25.82 | |
| P/TBV Ratio | 6.42 | 7.45 | - | - | - | - | |
| EV/Sales Ratio | 20884.02 | 51.49 | - | 31.69 | 23.20 | 22.52 | |
| Debt / Equity Ratio | 0.01 | 0.01 | -0.03 | 0.12 | 0.06 | 0.24 | |
| Net Debt / Equity Ratio | -1.39 | -2.56 | 0.48 | -1.96 | -0.83 | -1.37 | |
| Net Debt / EBITDA Ratio | 3.30 | 1.52 | 0.35 | 0.51 | 0.63 | 0.44 | |
| Net Debt / FCF Ratio | 4.71 | 1.45 | 0.47 | 0.71 | 0.65 | 0.29 | |
| Asset Turnover | 0 | 0.04 | - | 0.07 | 0.20 | 0.53 | |
| Quick Ratio | 9.69 | 7.10 | 0.91 | 1.60 | 1.61 | 0.98 | |
| Current Ratio | 9.79 | 7.34 | 1.00 | 3.52 | 1.84 | 1.13 | |
| Return on Equity (ROE) | -64.17% | - | - | -238.10% | -186.50% | - | |
| Return on Assets (ROA) | -26.12% | -61.33% | -72.03% | -47.99% | -62.28% | -61.59% | |
| Return on Capital Employed (ROCE) | -33.40% | -73.10% | -6391.50% | -88.30% | -118.20% | -141.10% | |
| Earnings Yield | -5.18% | -20.31% | -86.44% | -35.48% | -19.50% | -8.68% | |
| FCF Yield | -4.60% | -27.84% | -81.45% | -29.70% | -28.99% | -18.38% | |
| Buyback Yield / Dilution | -49.79% | -176.79% | -8.60% | -22.58% | -32.90% | -55.61% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.